The Pentagon Just Told You Where It's Spending

$5.3 billion for a radar company.

That's the check Shield AI just wrote.

The buyer builds AI-powered drones for the Pentagon. The target — Echodyne, based in Kirkland, Washington — makes compact radars that spot drones. About 260 employees. Products in more than 40 countries.

Shield AI doesn't launch rockets. It doesn't build satellites.

But at $28.8 billion, it's worth nearly as much as Rocket Lab.

Let me explain.

Shield AI raised $2.5 billion to fund the buy. A $1 billion Series H round. A $1 billion check from Blackstone. And $500 million in debt from JPMorgan.

That Series H priced Shield AI at $28.8 billion… up from $12.7 billion in March.

Eight months. The valuation more than doubled.

Rocket Lab's market cap sits near $32 billion. So a drone maker with no satellites is closing in on Rocket Lab — already the second-biggest space stock on the market.

Sound odd?

It shouldn't. Both companies chase the same customer — the Pentagon. They pull from the same budget.

And that budget just got tighter. Democrats swept both chambers of Congress last week.

The White House asked for $1.5 trillion in defense spending. That includes $71.1 billion for the Space Force. But the new Congress has other plans.

When budgets shrink, programs fight. Counter-drone radar competes with missile-tracking satellites. Ground sensors compete with orbital ones.

Every dollar that flows to Shield AI is one that doesn't flow to Rocket Lab or Northrop.

So where are the dollars going?

This deal gives you a clue.

Echodyne's MESA radars — built on patented metamaterials, small enough to mount on a drone — sit in counter-drone kits across 40 countries. Both firms expect triple-digit revenue growth this year. And Echodyne just opened a factory that can crank out 30,000 units a year.

Now, I know what you're thinking. "$5.3 billion for a startup with modest revenue? How does that work?"

Fair question.

Echodyne has raised about $200 million in total funding. Revenue is likely in the low tens of millions. Shield AI itself pulled roughly $300 million in the year through March 2025.

But the Pentagon doesn't pay for run-rate.

It pays for gear that works.

A radar small enough to ride a drone, cheap enough to mass-produce… and precise enough to track fast threats? The military funds that first. Everything else waits.

And Shield AI is betting on vertical integration. Drones, radar, software, autonomy — all under one roof. Same playbook SpaceX, Rocket Lab, and AST SpaceMobile run in orbit.

The difference? Shield AI runs it on the ground.

And it just wrote a $5.3 billion check to prove it.

If you own space stocks, watch this deal. Every dollar flowing to counter-drone radar is a dollar that doesn't reach orbit.

A $28.8 billion price tag for a company with no satellites tells you where the Pentagon sees its best return.

The budget is the battlefield…

Something strange is happening to your money.

It wasn't voted on. It wasn't debated in the Senate. And most Americans have no idea it's even taking place but…

President Trump is replacing the U.S. dollar.

Not with crypto. Not with a digital currency. Something far bigger than that – and it's already been signed and sealed in the back rooms of D.C., ready to be issued by the U.S. Treasury.

Bypassing every legal and political channel under the guise of "national security," Trump has enacted this total money reset using a landmark executive order (1421).

Whether you’re a Democrat or Republican, whether you support this new money or not, it doesn't matter.

Soon, every U.S. citizen will be forced to use Trump's New Dollar to fill their gas tank, buy groceries, and pay medical bills.

Which is why I've produced a critical new documentary laying out exactly what Trump's New Dollar means for your savings, your investments, and your family's financial future.

Detailing three important steps you can take today to prepare – including the name of a core band of assets connected to Trump’s initiative that could surge as a result.

As you’ll see in my briefing, the last time America reset its money like this – under Richard Nixon’s presidency in the 1970s – it created one of the greatest wealth divides in the history of our nation.

On one side, it minted an average of 1,300 new millionaires a day for over half a century. And on the other… the folks left behind, drowning in debt, with no idea how to use America’s new money to create wealth.

As Trump rolls out his new dollar, the question is:

Which side will you be on?

PS. If you’re wondering what Trump’s new money will look like, when it will be issued, what it means for your investments – all of those questions are answered in my briefing.

Shield says Echodyne will keep running its standalone radar business. That means it can still sell to customers who also buy from Shield's rivals. Echodyne joins Shield's Mission Systems unit, next to Vision Systems, which Shield built from its 2024 purchase of Sentient Vision Systems. Shield also wants Echodyne's radars to help it sell beyond the military, in areas such as public safety. Shield did not disclose Echodyne's revenue. Watch whether the standalone business keeps growing after the deal closes in early 2027.

In September, Echodyne won a contract with a $250 million ceiling from Joint Interagency Task Force 401. It covers counter-drone radar for U.S. and allied forces, and the Army issued it under Domestic Shield, a Department of War effort to protect key sites from drones. A ceiling is the most the government can order. It is not a promise to buy that much… Echodyne's new plant, a $40 million, 86,350-square-foot site, can build about 30,000 radars a year. Watch how much of that ceiling turns into real orders.

Aerospace and defense stocks fell Thursday on worries that a Democratic-controlled Congress could challenge the proposed $1.5 trillion defense budget, according to Benzinga. Rocket Lab fell 12% to $45.99 that day. Then it jumped 15% on Friday to $53.07, which put its market value near $32 billion. It rose about 10% more Monday morning ahead of earnings. Those swings show how fast budget worries move these stocks… and how fast they reverse. Watch tonight's Rocket Lab results, since the comparison in this story depends on its price.

Watch the calendar, not just the headline.

Tonight, Rocket Lab and AST SpaceMobile both report third-quarter results after the close. Rocket Lab ended Q2 with a record $2.36 billion backlog, and analysts expect about $257 million in revenue. Its stock fell 12%, rose 15%, then jumped about 10% in the last three sessions through Monday morning. So by the time you read this, the "nearly as big as Rocket Lab" comparison may have moved.

Next is Dec. 11. That is when the stopgap funding law runs out. The current Congress, with its current committee chairs, decides what happens first. New chairs take over in January.

Then early 2027. Shield expects to close the Echodyne deal then. Until it closes, Echodyne is a separate company. And up to $500 million of the price depends on performance targets that nobody outside the two firms has seen…

One more point on the budget. Defense stocks fell on worry that a new Congress could challenge the request. Worry is not a decision. No cuts have been made, and none have been proposed that we could find.

So watch tonight's earnings, the Dec. 11 deadline, and the closing date. Those three show whether private money is racing ahead of the budget, or reacting to it.

Let's keep this simple.

Say you sell your food truck. You think it will earn $100,000 next year. The buyer thinks it will earn $60,000. Nobody knows who is right yet.

So you make a deal. The buyer pays $90,000 today. And $10,000 more, but only if the truck really earns $100,000. That extra part is called an earn-out.

Shield's deal works the same way, only bigger. About $4.8 billion is paid and issued at closing. Up to $500 million more is paid only if Echodyne hits agreed performance targets. Those targets have not been made public.

Why do deals use this? When both sides expect fast growth but cannot prove it, an earn-out splits the risk. The seller gets paid for success. The buyer does not overpay for hope.

"Paid and issued" matters too. Part of the $4.8 billion is cash and part is Shield stock. Shield has not said how it splits. If a seller takes stock, it also takes the risk that the stock moves…

Both companies say they expect triple-digit revenue growth this year. That is exactly the kind of claim an earn-out is built to test.

Follow the part of the price that depends on the future, and you see where the two sides disagree.